Key result
Aspirin provides cardiovascular benefits not only through platelet inhibition but also via platelet-independent mechanisms including reduction of oxidative stress, inflammation, and endothelial dysfunction.
The cardiovascular benefits of aspirin are mediated not only by platelet COX-1 inhibition but also by potent anti-inflammatory and antioxidant effects of its salicylate metabolite.
Answers are grounded in this paper and cite their sources.
May broaden mechanistic rationale for aspirin; leaves open whether non-platelet effects should guide dosing or selection.
There is a close inter-relationship between oxidative stress, coagulation, inflammation, and smooth muscle cell growth as key components of atherosclerosis (Fig. 1). As an analgesic and anti-pyretic, aspirin has been in use for over a century. It acetylates the COX enzyme, irreversibly inhibiting the formation of prostaglandin. Its action on platelet TxA2 has highlighted its role as an anti-thrombotic agent in cardiovascular patients. Over the last two decades, unique anti-inflammatory properties of aspirin not shared by other non-steroidals have been discovered. Aspirin biotransforms into salicylate, which has diverse but potent anti-inflammatory properties. As we strive to better understand the concepts of atherogenesis, chronic inflammation, oxidative stress, and endothelial activation, these novel effects of aspirin provide new insights as to how this wonder drug works. These effects of aspirin alter many, if not all, components of the atherogenesis cascade shown in Fig. 1.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2005) conducted a review in Atherosclerosis. Aspirin was evaluated. Aspirin provides cardiovascular benefits not only through platelet inhibition but also via platelet-independent mechanisms including reduction of oxidative stress, inflammation, and endothelial dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: